Actual Medicinal Product (AMP) - Risperdal Consta 37.5mg powder and solvent for prolonged-release suspension for injection vials (Janssen-Cilag Ltd)

Navigation

Name Details

Name Start Date End Date
Name Current Name Risperdal Consta 37.5mg powder and solvent for prolonged-release suspension for injection vials Start Date 01-12-2024 End Date
Previous Name Previous Name Risperdal Consta 37.5mg powder and solvent for suspension for injection vials Start Date 09-06-2004 End Date 30-11-2024
Abbreviated Name Abbreviated Name Risperdal Consta 37.5mg inj vials Start Date 01-05-2009
Previous Abbreviated Name Risperdal Consta 37.5mg pdr & solv for susp for inj vials Previous Start Date 14-09-2004 Previous End Date 30-04-2009

Summary

Licensed Route
Intramuscular
Availability Restrictions
None
Licensing Authority
Medicines - MHRA/EMA
EMA Indicator

Codes

BNF Start Date End Date
Previous BNF 04020200 Start Date 14-06-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
4166711000001102 27-03-2003

Parent Products

Actual Medicinal Product Pack (AMPP) Information

Pack Size Indicative Price Discontinued
1 vial 11132